Nasdaq News

Live cattle futures posted modest losses of 57 cents to $1.42 at the Monday close. Cash trade has yet to be reported this week, with Monday mostly compiling showlists, as trade has been light in recent weeks. Feeder cattle futures were down $1.32 to $3.02 on Monday. The CME Feeder...

Key PointsThe Director traded 400 shares at $351.11 per share for a total value of $140,444 on September 17, 2026.

In trading on Tuesday, the WisdomTree Artificial Intelligence and Innovation Fund ETF is outperforming other ETFs, up about 1.9% on the day. Components of that ETF showing particular strength include shares of Bloom Energy, up about 12.3% and shares of Cerebras Systems, up abou

Key PointsYour spousal benefits may equal up to 50% of your spouse's monthly benefit.

Key PointsThe Vanguard Total International Stock ETF (VXUS) lets you invest in the entire international market at once.

(RTTNews) - On Tuesday, Veracyte (VCYT) announced new findings from a retrospective analysis of the Phase 3 NRG/RTOG 0815 trial showing that its Decipher Prostate Genomic Classifier can identify intermediate-risk prostate cancer patients more likely to benefit from adding short-t

(RTTNews) - Eli Lilly (LLY) said a new analysis found that people taking Zepbound 15 mg lost an average of 4.5% more body weight than those taking Wegovy HD at 72 weeks. The comparison was based on data from separate studies rather than a direct head-to-head trial.

Key PointsVertiv Holdings provides the power management and cooling systems that keep AI data centers from overheating.

(RTTNews) - Moleculin Biotech (MBRX) has completed enrolment in Part A of its pivotal Phase 2/3 MIRACLE trial evaluating Annamycin in combination with cytarabine (AnnAraC) in adults with relapsed or refractory acute myeloid leukemia.

Key PointsArtificial intelligence (AI) is a massive part of SpaceX's business, with analysts projecting it could bring in $275 billion in revenue by the end of the decade.

Key PointsViking Therapeutics is a healthcare company that has a promising GLP-1 drug in its portfolio.

Key PointsColgate-Palmolive, Procter & Gamble, and Coca-Cola have durable businesses that can pay you for a lifetime.

Key PointsCME dominates the global derivatives market with exceptional profitability and high net margins.

Key PointsIn a challenging environment, Carnival continues to deliver growth and higher yields.

Key PointsNu stock took a $6.5 billion hit on Monday after unconfirmed reports had it interested in acquiring a European fintech platform.

(RTTNews) - Following the weakness seen in the previous session, stocks have shown a lack of direction over the course of the trading day on Tuesday. The major averages have spent the day bouncing back and forth across the unchanged line.

(RTTNews) - Tuesday, American asset manager Nuveen LLC announced that the Court has sanctioned the Scheme of Arrangement for the recommended cash acquisition of Schroders plc (SDR.L) by Bidco, a subsidiary of Nuveen.

(RTTNews) - Tuesday, Ernexa Therapeutics (ERNA) said it has been selected for the Emerging Track at the 2026 Cell & Gene Meeting on the Mesa, where CEO Sanjeev Luther will present the company's oncology strategy and lead candidate ERNA-101.

Key PointsYear to date, Monster Beverage stock is up about about 10%, trailing the 12.5% return of the S&P 500.

Key PointsUPS shares have hit a rocky patch, but that performance just doesn’t reflect the company’s likely future.